Seasonal and intraspecific variability of chlorophyll fluorescence, pigmentation and growth of Pinus ponderosa subjected to elevated CO{sub 2}

Atmospheric CO{sub 2}2 is expected to double in the next century, and these increases will have substantial impact on forest ecosystems. However, the database on the effects of elevated CO{sub 2} on forests is limited, and the extent of intraspecific variability remains unknown. We are investigating the effects of elevated CO{sub 2} on the intraspecific variability of quantum yield (as measured through chlorophyll fluorescence Fv/Fm ratio) and pigmentation, and how these are correlated to variability in growth. Four-year-old Pinus ponderosa seedlings were obtained from nine different sources across California. These seedlings were grown in standard outdoor exposure chambers for sixteen months at either ambient levels of CO{sub 2}, ambient+175ppm CO{sub 2}, or ambient+350ppm CO{sub 2}. The seedlings were periodically measured for growth, pigmentation, and chlorophyll fluorescence. The results showed a variable growth response of the nine sources during all measurement periods. Increasing CO{sub 2} resulted in a decrease in Fv/Fm among sources ranging from {minus}2.1% to {minus}23.2% in February, and 3.1% to {minus}12.5% in June. The source that had the best growth throughout the study, also had a minimal reduction in quantum yield (Fv/Fm) in the presence of elevated CO{sub 2}. For the seedlings of fastest growing sources, the correspondence between total growth and chlorophyll fluorescence was strongest during the February measurement period. Our results also showed a significant reduction in pigmentation due to increased CO{sub 2}. There are at least three explanations for the different responses during each measurement periods. First, the trees could be adapting favorably to increasing CO{sub 2}. Secondly, 1993 needles could be under less physiological stress than the current year needles. Third, there is a seasonal effect dependent upon temperature or light which is influencing the Fv/Fm ratio and pigmentation

The Origins of Concentric Demyelination: Self-Organization in the Human Brain

Baló's concentric sclerosis is a rare atypical form of multiple sclerosis characterized by striking concentric demyelination patterns. We propose a robust mathematical model for Baló's sclerosis, sharing common molecular and cellular mechanisms with multiple sclerosis. A reconsideration of the analogies between Baló's sclerosis and the Liesegang periodic precipitation phenomenon led us to propose a chemotactic cellular model for this disease. Rings of demyelination appear as a result of self-organization processes, and closely mimic Baló lesions. According to our results, homogeneous and concentric demyelinations may be two different macroscopic outcomes of a single fundamental immune disorder. Furthermore, in chemotactic models, cellular aggressivity appears to play a central role in pattern formation

Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey

Alesia Sadosky,1 Caroline Schaefer,2 Rachael Mann,3 Felicia Bergstrom,2 Rebecca Baik,2 Bruce Parsons,1 Srinivas Nalamachu,4 Edward Nieshoff,5 Brett R Stacey,6 Alan Anschel,7 Michael Tuchman81Pfizer Inc, New York, NY, 2Covance Market Access Services Inc, Gaithersburg, MD, 3Covance Market Access Services Inc, San Diego, CA, 4International Clinical Research Institute, Overland Park, KS, 5Rehabilitation Institute of Michigan/Wayne State University, Detroit, MI, 6Oregon Health and Science University, Portland, OR, 7Rehabilitation Institute of Chicago, Chicago, IL, 8Palm Beach Neurological Center, Palm Beach Gardens, FL, USABackground: The purpose of this study was to characterize the burden of illness among adult subjects with painful diabetic peripheral neuropathy (pDPN) seeking treatment in the US.Methods: This observational study recruited 112 subjects with pDPN during routine visits from general practitioner and specialist sites. Subjects completed a one-time questionnaire, which included demographics, symptom duration, health care resource use, out-of-pocket costs, employment status, and validated measures that assessed pain, functioning, sleep, anxiety and depression, health status, and productivity. Investigators completed a case report form based on a 6-month retrospective chart review to capture clinical information, pDPN-related treatments, and other pDPN-related health care resource use over the past 6 months. Annualized costs were extrapolated based on reported 6-month health care resource use.Results: The mean age of the subjects was 61.1 years, 52.7% were female, and 17.9% were in paid employment. The most common comorbid conditions were sleep disturbance/insomnia (43.8%), depressive symptoms (41.1%), and anxiety (35.7%). The mean pain severity score was 5.2 (0–10 scale), and 79.5% reported moderate or severe pain. The mean pain interference with function score was 5.0 (0–10 scale) overall, with 2.0 among mild, 5.1 among moderate, and 7.0 among severe. The mean Medical Outcomes Study sleep problems index score was 48.5 (0–100 scale). The mean health state utility score was 0.61. Among subjects employed for pay, mean overall work impairment was 43.6%. Across all subjects, mean overall activity impairment was 52.3%. In total, 81.3% were prescribed at least one medication for their pDPN; 50.9% reported taking at least one nonprescription medication. Adjusted mean annualized total direct and indirect costs per subject were $4841 and$9730, respectively. Outcomes related to pain interference with function, sleep, health status, activity impairment, prescription medication use, and direct and indirect costs were significantly worse among subjects with more severe pain (P < 0.0020).Conclusion: Subjects with pDPN exhibited high pain levels, which were associated with poor sleep, function, and productivity. Health care resource utilization in pDPN was prevalent and costs increased with greater pain severity. The burden of pDPN was greater among subjects with greater pain severity.Keywords: painful diabetic peripheral neuropathy, pain assessment, burden of illness, quality of life, treatment patterns, health care resource use, costs, productivit